Autolus Therapeutics vs Century Therapeutics
AUTL and IPSC side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AUTL and IPSC compare
Autolus Therapeutics and Century Therapeutics are about the same size, with market caps of $311M and $299M.
Century Therapeutics scores higher on the StockData Score (8 against 4 for Autolus Therapeutics), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AUTL | IPSC |
|---|---|---|
| Size and price | ||
| Market cap | $311M | $299M |
| Share price | $1.17 | $1.65 |
| Change, 1 year | −14.0% | 193% |
| Change, 5 years | −81.2% | −92.0% |
| Beta (5Y) | 1.84 | 1.36 |
| Employees | 754 | 78 |
| StockData Score | ||
| Total score | 4 | 8 (better) |
| Valuation score | 0 | 1 (better) |
| Growth score | 3 (better) | 1 |
| Performance score | 0 | 1 (better) |
| Health score | 1 | 5 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 2.3× | – |
| P/B | 11.4× | 1.4× (better) |
| FCF yield | −57.9% | −28.5% (better) |
| Growth | ||
| Revenue growth (TTM) | 169% | – |
| Profitability | ||
| Gross margin | 35.8% | – |
| Operating margin | −160% | – |
| Net margin | −186% | – |
| FCF margin | −131% | – |
| Return on equity | −175% | −51.2% (better) |
| Return on invested capital | – | −126% |
| Financial health | ||
| Debt / equity | – | 0.00 |
| Interest coverage | −4.8× | – |
| Current ratio | 3.72 | 8.74 (better) |
| Altman Z-score | −4.28 | −2.08 (better) |
| Piotroski F-score | 2 | 4 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | −0.23% |
| Shareholder yield | 0.00% (better) | −0.23% |
| Ownership | ||
| Held by institutions | 49.7% | 87.3% |
| Held by insiders | 24.6% | 3.8% |
| Insider net buying, 12 months | −$15.7K | $10.6K (better) |
| Short interest, % of float | – | 18.4% |
Go deeper
- AUTL stock overview
- AUTL income statement
- AUTL valuation and score
- IPSC stock overview
- IPSC income statement
- IPSC valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.